Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912509 · ClinicalTrials.gov registry record · NA
Cross Linking for Treatment of Corneal Infection
A NA study, sponsored by Price Vision Group.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00912509 is a NA study that was terminated before completion, run by Price Vision Group. The registered enrollment target is 30 participants.
The verdict
NCT00912509, a NA study, was terminated before completion, sponsored by Price Vision Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.
Interventions
- DRUG riboflavin
- DEVICE UVX Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00912509
The ClinicalTrials.gov registry entry for NCT00912509 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Price Vision Group, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which riboflavin is the first listed.
NCT00912509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00912509 about?
NCT00912509 is a clinical study titled "Cross Linking for Treatment of Corneal Infection". This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.
What is the current status of trial NCT00912509?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2009-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00912509?
The interventions under investigation include: riboflavin (DRUG), UVX Light (DEVICE).
Who is sponsoring clinical trial NCT00912509?
This trial is sponsored by Price Vision Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.